Analyzing immunosuppressive characteristics of metastatic melanoma patients before the treatment, we observed that some patients were characterized by increased MDSC frequency and immunosuppression as well as by high concentrations of MDSC-related cytokines (IL-6, IL-8). This evidence concerns the gene IL6 and metastatic melanoma.